Safety and Efficacy Study of Sivelestat in Neuromyelitis Optica Spectrum Disorder
NCT07738952
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
7
Enrollment
OTHER
Sponsor class
Conditions
Neuromyelitis Optica Spectrum Disorder Attack
Interventions
DRUG:
Sivelestat sodium hydrate
Sponsor
Kyushu University